ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Lava tunnels offer insights into the geological forces that continue to shape the island nation
Researchers have found a domain on a Wnt protein that allows it to stick to vesicles
Test your knowledge of the oils, balms, and waxes that help us care for facial hair.
Up to 10 of the 19 faculty positions are slated to be eliminated, unless alternative cost-saving measures are found
Regeneron-backed start-up has $52 million to begin testing its lead candidate in people
Spin-out from Ed Tate’s lab focuses on improving conjugate chemistry in the popular anticancer modality
2024 authorizations kept a steady clip and gave people some new treatment options
The headlines and highlights that the C&EN team found noteworthy this year
The legislation aims to break ties between the US pharma industry and a few Chinese services firms
Up to 10 of the 19 faculty positions are slated to be eliminated, unless alternative cost-saving measures are found
Final rule allows current uses of the toxic solvent with a new inhalation limit
Trichloroethylene and perchloroethylene phase-out plan includes exemptions for some critical applications
Researchers have found a domain on a Wnt protein that allows it to stick to vesicles
Small molecules hint at a new treatment option for the inherited blood disorder
Spin-out from Ed Tate’s lab focuses on improving conjugate chemistry in the popular anticancer modality